Francine Grodstein, Sc.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Urinary Incontinence | 33 | 2023 | 496 | 8.440 |
Why?
|
Cognition Disorders | 71 | 2023 | 3985 | 6.000 |
Why?
|
Cognition | 92 | 2024 | 7075 | 5.670 |
Why?
|
Aging | 62 | 2024 | 8764 | 3.840 |
Why?
|
Nurses | 43 | 2024 | 2494 | 3.840 |
Why?
|
Estrogen Replacement Therapy | 34 | 2018 | 1209 | 3.080 |
Why?
|
Urinary Incontinence, Stress | 9 | 2023 | 182 | 2.860 |
Why?
|
Diet, Mediterranean | 11 | 2024 | 744 | 2.430 |
Why?
|
Urinary Incontinence, Urge | 6 | 2020 | 50 | 2.420 |
Why?
|
Postmenopause | 33 | 2024 | 2518 | 1.940 |
Why?
|
Alzheimer Disease | 28 | 2024 | 8747 | 1.830 |
Why?
|
Dementia | 22 | 2024 | 2729 | 1.710 |
Why?
|
C-Peptide | 6 | 2012 | 443 | 1.620 |
Why?
|
Aged | 211 | 2024 | 171562 | 1.480 |
Why?
|
Urinary Bladder, Overactive | 2 | 2022 | 119 | 1.440 |
Why?
|
Health Behavior | 15 | 2020 | 2647 | 1.390 |
Why?
|
Hormone Replacement Therapy | 11 | 2016 | 756 | 1.330 |
Why?
|
Prospective Studies | 114 | 2024 | 54920 | 1.230 |
Why?
|
Fecal Incontinence | 6 | 2019 | 246 | 1.200 |
Why?
|
Diet | 21 | 2023 | 8090 | 1.180 |
Why?
|
Vitamin D | 8 | 2023 | 3310 | 1.150 |
Why?
|
Neuropsychological Tests | 36 | 2024 | 7145 | 1.150 |
Why?
|
Antioxidants | 8 | 2012 | 1673 | 1.140 |
Why?
|
Female | 277 | 2024 | 397089 | 1.130 |
Why?
|
Dietary Supplements | 14 | 2022 | 3443 | 1.090 |
Why?
|
Fruit | 8 | 2018 | 1164 | 1.070 |
Why?
|
Apolipoprotein E4 | 6 | 2022 | 711 | 1.050 |
Why?
|
Aged, 80 and over | 84 | 2024 | 59686 | 1.040 |
Why?
|
Middle Aged | 186 | 2024 | 223491 | 0.980 |
Why?
|
Health Status | 13 | 2019 | 4094 | 0.980 |
Why?
|
Humans | 334 | 2024 | 768393 | 0.950 |
Why?
|
Longitudinal Studies | 42 | 2024 | 14784 | 0.890 |
Why?
|
Estrogens, Conjugated (USP) | 9 | 2018 | 277 | 0.860 |
Why?
|
Cohort Studies | 72 | 2024 | 41795 | 0.850 |
Why?
|
Women's Health | 14 | 2024 | 2078 | 0.850 |
Why?
|
Longevity | 8 | 2024 | 1077 | 0.830 |
Why?
|
Infertility, Female | 8 | 2016 | 765 | 0.820 |
Why?
|
Vitamins | 5 | 2021 | 1637 | 0.820 |
Why?
|
Juglans | 1 | 2023 | 45 | 0.820 |
Why?
|
Risk Factors | 105 | 2024 | 74962 | 0.810 |
Why?
|
Memory | 16 | 2024 | 2210 | 0.810 |
Why?
|
Alcohol Drinking | 12 | 2019 | 4049 | 0.750 |
Why?
|
Amyloid beta-Peptides | 7 | 2023 | 3910 | 0.740 |
Why?
|
Flavonoids | 3 | 2014 | 447 | 0.710 |
Why?
|
United States | 84 | 2024 | 73150 | 0.680 |
Why?
|
Neurodegenerative Diseases | 2 | 2021 | 1094 | 0.670 |
Why?
|
Epigenesis, Genetic | 3 | 2024 | 3827 | 0.670 |
Why?
|
Caffeine | 4 | 2012 | 702 | 0.670 |
Why?
|
Exercise | 16 | 2022 | 5946 | 0.660 |
Why?
|
Nuts | 3 | 2023 | 264 | 0.660 |
Why?
|
Telomere | 4 | 2020 | 943 | 0.650 |
Why?
|
Photoperiod | 1 | 2020 | 141 | 0.650 |
Why?
|
Health Surveys | 15 | 2020 | 4056 | 0.630 |
Why?
|
Vitamin E | 5 | 2012 | 874 | 0.610 |
Why?
|
Body Mass Index | 27 | 2021 | 13052 | 0.610 |
Why?
|
Medroxyprogesterone Acetate | 4 | 2017 | 156 | 0.610 |
Why?
|
beta Carotene | 4 | 2015 | 523 | 0.600 |
Why?
|
Odds Ratio | 26 | 2022 | 9682 | 0.590 |
Why?
|
Educational Status | 9 | 2015 | 2518 | 0.590 |
Why?
|
Cardiovascular Diseases | 25 | 2023 | 15649 | 0.580 |
Why?
|
Adult | 114 | 2024 | 223640 | 0.580 |
Why?
|
Fishes | 3 | 2018 | 606 | 0.570 |
Why?
|
Follow-Up Studies | 50 | 2023 | 39407 | 0.570 |
Why?
|
Seafood | 2 | 2018 | 395 | 0.560 |
Why?
|
Diabetes Mellitus, Type 2 | 12 | 2023 | 12241 | 0.560 |
Why?
|
Life Style | 16 | 2022 | 3929 | 0.550 |
Why?
|
Memory Disorders | 6 | 2014 | 1203 | 0.550 |
Why?
|
Disabled Persons | 3 | 2017 | 1215 | 0.550 |
Why?
|
Estrogens | 10 | 2010 | 1534 | 0.540 |
Why?
|
Hip Fractures | 7 | 2018 | 996 | 0.530 |
Why?
|
Fertility | 3 | 2019 | 772 | 0.530 |
Why?
|
Incidence | 44 | 2020 | 21544 | 0.520 |
Why?
|
Insulin | 6 | 2013 | 6607 | 0.520 |
Why?
|
Memory, Short-Term | 4 | 2022 | 1010 | 0.510 |
Why?
|
Homocysteine | 3 | 2014 | 637 | 0.510 |
Why?
|
Cerebrovascular Disorders | 3 | 2021 | 1486 | 0.510 |
Why?
|
Diet Surveys | 3 | 2018 | 1160 | 0.500 |
Why?
|
Gonadal Steroid Hormones | 2 | 2016 | 708 | 0.490 |
Why?
|
Dietary Fats | 3 | 2012 | 2003 | 0.460 |
Why?
|
Menopause | 9 | 2018 | 1653 | 0.460 |
Why?
|
Quality of Life | 9 | 2023 | 13503 | 0.460 |
Why?
|
Attention | 5 | 2017 | 2425 | 0.450 |
Why?
|
Age of Onset | 8 | 2024 | 3345 | 0.450 |
Why?
|
Vegetables | 5 | 2018 | 1198 | 0.450 |
Why?
|
Carotenoids | 3 | 2020 | 620 | 0.450 |
Why?
|
Epidemiologic Studies | 8 | 2021 | 678 | 0.450 |
Why?
|
Fertility Agents, Female | 1 | 2014 | 101 | 0.440 |
Why?
|
Multivariate Analysis | 26 | 2019 | 12092 | 0.440 |
Why?
|
Resilience, Psychological | 3 | 2023 | 805 | 0.440 |
Why?
|
Logistic Models | 24 | 2019 | 13323 | 0.440 |
Why?
|
Reproductive Techniques, Assisted | 3 | 2016 | 503 | 0.440 |
Why?
|
Progestins | 8 | 2008 | 302 | 0.430 |
Why?
|
Disease Progression | 11 | 2020 | 13646 | 0.430 |
Why?
|
Social Behavior | 1 | 2020 | 1146 | 0.430 |
Why?
|
Residence Characteristics | 6 | 2024 | 2122 | 0.430 |
Why?
|
Medicare | 12 | 2024 | 6881 | 0.420 |
Why?
|
Biliary Tract Neoplasms | 3 | 2020 | 187 | 0.420 |
Why?
|
Weight Gain | 6 | 2018 | 2356 | 0.420 |
Why?
|
Apolipoproteins E | 7 | 2022 | 1459 | 0.420 |
Why?
|
Genome-Wide Association Study | 8 | 2024 | 12778 | 0.410 |
Why?
|
DNA Methylation | 3 | 2022 | 4421 | 0.410 |
Why?
|
Ascorbic Acid | 4 | 2015 | 658 | 0.400 |
Why?
|
Nervous System Diseases | 1 | 2023 | 1664 | 0.400 |
Why?
|
Hypercholesterolemia | 2 | 2019 | 1142 | 0.390 |
Why?
|
Proportional Hazards Models | 22 | 2021 | 12558 | 0.390 |
Why?
|
Coronary Disease | 9 | 2006 | 5924 | 0.390 |
Why?
|
Polymorphism, Single Nucleotide | 8 | 2024 | 16028 | 0.390 |
Why?
|
Time Factors | 33 | 2024 | 40272 | 0.390 |
Why?
|
Age Factors | 23 | 2021 | 18471 | 0.380 |
Why?
|
Research | 1 | 2020 | 1981 | 0.380 |
Why?
|
Learning | 3 | 2022 | 1761 | 0.370 |
Why?
|
Parity | 6 | 2014 | 938 | 0.370 |
Why?
|
Male | 89 | 2024 | 364902 | 0.370 |
Why?
|
Vitamin B Complex | 2 | 2014 | 299 | 0.360 |
Why?
|
Risk | 19 | 2012 | 9636 | 0.360 |
Why?
|
Parkinsonian Disorders | 2 | 2024 | 285 | 0.350 |
Why?
|
Contraceptives, Oral | 4 | 2016 | 562 | 0.350 |
Why?
|
Phobic Disorders | 1 | 2013 | 441 | 0.350 |
Why?
|
Peptide Fragments | 4 | 2022 | 5151 | 0.340 |
Why?
|
Obesity | 13 | 2020 | 13084 | 0.340 |
Why?
|
Depression | 7 | 2021 | 8241 | 0.340 |
Why?
|
Drinking | 1 | 2011 | 197 | 0.340 |
Why?
|
Central Nervous System Stimulants | 2 | 2012 | 1181 | 0.340 |
Why?
|
Psychological Tests | 7 | 2012 | 643 | 0.340 |
Why?
|
Confidence Intervals | 12 | 2019 | 2931 | 0.320 |
Why?
|
Feeding Behavior | 5 | 2020 | 3203 | 0.320 |
Why?
|
Health | 1 | 2012 | 399 | 0.320 |
Why?
|
Motor Activity | 2 | 2010 | 2720 | 0.320 |
Why?
|
Patient Acceptance of Health Care | 3 | 2019 | 3231 | 0.320 |
Why?
|
Fasting | 3 | 2012 | 1610 | 0.310 |
Why?
|
Severity of Illness Index | 9 | 2019 | 15939 | 0.310 |
Why?
|
Insulin-Like Growth Factor I | 2 | 2006 | 1943 | 0.300 |
Why?
|
Socioeconomic Factors | 10 | 2021 | 7861 | 0.300 |
Why?
|
Linear Models | 14 | 2017 | 5878 | 0.300 |
Why?
|
Nutritional Status | 4 | 2023 | 1627 | 0.290 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 3 | 2008 | 2276 | 0.290 |
Why?
|
Contraceptives, Oral, Hormonal | 1 | 2009 | 190 | 0.290 |
Why?
|
Regression Analysis | 11 | 2014 | 6350 | 0.290 |
Why?
|
Tocopherols | 1 | 2007 | 44 | 0.290 |
Why?
|
Observation | 3 | 2008 | 311 | 0.280 |
Why?
|
Terminal Care | 1 | 2019 | 1773 | 0.280 |
Why?
|
Telephone | 7 | 2012 | 630 | 0.280 |
Why?
|
Cross-Sectional Studies | 22 | 2024 | 26375 | 0.280 |
Why?
|
Atherosclerosis | 1 | 2023 | 3431 | 0.280 |
Why?
|
Stress Disorders, Post-Traumatic | 5 | 2024 | 4641 | 0.280 |
Why?
|
Waist-Hip Ratio | 1 | 2008 | 520 | 0.270 |
Why?
|
Cholecalciferol | 2 | 2021 | 557 | 0.270 |
Why?
|
Environmental Exposure | 6 | 2024 | 4528 | 0.270 |
Why?
|
Chronic Disease | 8 | 2019 | 9379 | 0.260 |
Why?
|
Hypertension | 5 | 2019 | 8615 | 0.260 |
Why?
|
Nootropic Agents | 1 | 2007 | 159 | 0.260 |
Why?
|
Adiposity | 3 | 2018 | 1895 | 0.250 |
Why?
|
Prevalence | 14 | 2019 | 15872 | 0.250 |
Why?
|
Vitamin B 12 Deficiency | 1 | 2006 | 119 | 0.250 |
Why?
|
Smoking | 15 | 2019 | 9111 | 0.250 |
Why?
|
Reproductive History | 2 | 2004 | 210 | 0.250 |
Why?
|
Double-Blind Method | 8 | 2021 | 12456 | 0.250 |
Why?
|
Folic Acid | 3 | 2008 | 1336 | 0.250 |
Why?
|
Age Distribution | 9 | 2014 | 2877 | 0.240 |
Why?
|
Tooth Loss | 2 | 1998 | 200 | 0.240 |
Why?
|
Geriatric Assessment | 4 | 2020 | 1422 | 0.240 |
Why?
|
Meat | 3 | 2013 | 588 | 0.240 |
Why?
|
Psychomotor Performance | 3 | 2021 | 1895 | 0.240 |
Why?
|
Self Report | 5 | 2020 | 3766 | 0.230 |
Why?
|
Verbal Learning | 4 | 2022 | 465 | 0.230 |
Why?
|
Arthritis, Rheumatoid | 4 | 2013 | 3777 | 0.230 |
Why?
|
Case-Control Studies | 20 | 2023 | 22296 | 0.230 |
Why?
|
Snoring | 1 | 2006 | 211 | 0.230 |
Why?
|
Fee-for-Service Plans | 2 | 2019 | 714 | 0.220 |
Why?
|
Constriction | 1 | 2023 | 168 | 0.220 |
Why?
|
Drug Administration Schedule | 7 | 2017 | 4859 | 0.220 |
Why?
|
Interviews as Topic | 6 | 2013 | 2740 | 0.220 |
Why?
|
Brain | 12 | 2024 | 27454 | 0.220 |
Why?
|
Occupations | 1 | 2005 | 519 | 0.210 |
Why?
|
Mental Health | 6 | 2019 | 3276 | 0.210 |
Why?
|
Cholelithiasis | 3 | 1999 | 408 | 0.210 |
Why?
|
Caloric Restriction | 2 | 2023 | 300 | 0.210 |
Why?
|
Autopsy | 2 | 2024 | 1013 | 0.200 |
Why?
|
Reference Values | 5 | 2018 | 4941 | 0.200 |
Why?
|
Neuroprotective Agents | 1 | 2009 | 957 | 0.200 |
Why?
|
Income | 2 | 2014 | 1877 | 0.200 |
Why?
|
Hearing Loss | 2 | 2020 | 786 | 0.200 |
Why?
|
Diabetes Complications | 1 | 2008 | 1322 | 0.190 |
Why?
|
Task Performance and Analysis | 1 | 2005 | 771 | 0.190 |
Why?
|
Hyperhomocysteinemia | 2 | 2014 | 118 | 0.190 |
Why?
|
Hand Strength | 1 | 2024 | 466 | 0.180 |
Why?
|
Aspirin | 3 | 2008 | 3135 | 0.180 |
Why?
|
Mortality | 3 | 2023 | 2917 | 0.180 |
Why?
|
Defecation | 2 | 2023 | 191 | 0.170 |
Why?
|
Colorectal Neoplasms | 6 | 2018 | 6971 | 0.170 |
Why?
|
Predictive Value of Tests | 5 | 2020 | 15455 | 0.170 |
Why?
|
Delayed Diagnosis | 1 | 2024 | 469 | 0.170 |
Why?
|
Delirium | 2 | 2023 | 1695 | 0.170 |
Why?
|
CpG Islands | 2 | 2022 | 1209 | 0.170 |
Why?
|
Venous Thromboembolism | 3 | 2018 | 1881 | 0.170 |
Why?
|
Particulate Matter | 1 | 2012 | 2609 | 0.170 |
Why?
|
Insurance Claim Review | 3 | 2019 | 746 | 0.170 |
Why?
|
Parturition | 2 | 2020 | 453 | 0.170 |
Why?
|
Oxidative Stress | 3 | 2009 | 3139 | 0.170 |
Why?
|
Health Promotion | 2 | 2022 | 2209 | 0.170 |
Why?
|
Infant, Low Birth Weight | 1 | 2024 | 875 | 0.160 |
Why?
|
Isoflavones | 1 | 2000 | 139 | 0.160 |
Why?
|
Stress, Psychological | 3 | 2023 | 4543 | 0.160 |
Why?
|
Vascular Malformations | 2 | 2015 | 469 | 0.160 |
Why?
|
Marital Status | 2 | 2015 | 426 | 0.160 |
Why?
|
Coffee | 1 | 2003 | 598 | 0.160 |
Why?
|
Fallopian Tube Diseases | 3 | 1994 | 60 | 0.160 |
Why?
|
Cataract Extraction | 1 | 2003 | 465 | 0.160 |
Why?
|
Executive Function | 3 | 2017 | 1405 | 0.160 |
Why?
|
Geriatrics | 1 | 2023 | 390 | 0.160 |
Why?
|
Survivors | 1 | 2009 | 2382 | 0.160 |
Why?
|
Glutens | 1 | 2021 | 240 | 0.160 |
Why?
|
Recovery of Function | 2 | 2019 | 2990 | 0.160 |
Why?
|
Risk Assessment | 13 | 2020 | 24318 | 0.150 |
Why?
|
Osteoarthritis, Hip | 1 | 2003 | 409 | 0.150 |
Why?
|
Heart Valve Prosthesis Implantation | 2 | 2019 | 1568 | 0.150 |
Why?
|
Walking | 2 | 2011 | 1201 | 0.150 |
Why?
|
Comorbidity | 8 | 2017 | 10588 | 0.150 |
Why?
|
Coronary Artery Disease | 3 | 2003 | 6567 | 0.150 |
Why?
|
Reproducibility of Results | 8 | 2012 | 20224 | 0.150 |
Why?
|
Gallbladder Neoplasms | 1 | 2019 | 191 | 0.150 |
Why?
|
Happiness | 1 | 2019 | 170 | 0.150 |
Why?
|
Diagnostic Self Evaluation | 2 | 2019 | 227 | 0.150 |
Why?
|
Activities of Daily Living | 3 | 2022 | 2433 | 0.150 |
Why?
|
Consanguinity | 1 | 2019 | 460 | 0.140 |
Why?
|
Nonlinear Dynamics | 1 | 2020 | 494 | 0.140 |
Why?
|
Lead | 3 | 2014 | 880 | 0.140 |
Why?
|
Parkinson Disease | 3 | 2023 | 2895 | 0.140 |
Why?
|
Statistics as Topic | 4 | 2016 | 2363 | 0.140 |
Why?
|
Craniocerebral Trauma | 1 | 2021 | 495 | 0.140 |
Why?
|
Movement Disorders | 1 | 2021 | 464 | 0.140 |
Why?
|
Reproductive Physiological Phenomena | 1 | 2016 | 4 | 0.140 |
Why?
|
Cataract | 1 | 2003 | 837 | 0.140 |
Why?
|
Attitude to Health | 1 | 2006 | 2025 | 0.140 |
Why?
|
Adult Survivors of Child Abuse | 1 | 2020 | 301 | 0.140 |
Why?
|
Body Size | 1 | 2019 | 463 | 0.140 |
Why?
|
Parathyroid Hormone | 1 | 2023 | 1804 | 0.140 |
Why?
|
Cerebral Amyloid Angiopathy | 1 | 2024 | 892 | 0.130 |
Why?
|
Breast Feeding | 1 | 2004 | 1364 | 0.130 |
Why?
|
Sleep Initiation and Maintenance Disorders | 1 | 2006 | 1099 | 0.130 |
Why?
|
Quantitative Trait Loci | 1 | 2024 | 2127 | 0.130 |
Why?
|
Cholecystectomy | 2 | 1999 | 409 | 0.130 |
Why?
|
Risk Reduction Behavior | 2 | 2020 | 1118 | 0.130 |
Why?
|
Genotype | 7 | 2019 | 13042 | 0.130 |
Why?
|
Health Services for the Aged | 1 | 2018 | 258 | 0.130 |
Why?
|
Ovulation | 2 | 1994 | 181 | 0.130 |
Why?
|
|